The federal Food and Drug Administration today approved an updated label for Johnson & Johnson's Ortho Evra birth control patch that gives heightened emphasis to the risk of serious blood clots ...

U.S. drug advisers recommended that the label for Johnson and Johnson's Ortho Evra birth control patch be simplified to better explain the risk of blood clots.

The FDA may remove the warning labels on hormone replacement therapies used to treat the symptoms of menopause. Doctors say ...